Oncology
Gastroenteropancreatic Neuroendocrine Tumors
Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2024 ASCO-GI Cancers Symposium
Overview
<p><em>Conference Reporter </em>delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. <em>Conference Reporter</em> will feature community-selected experts and topics in Gastroenteropancreatic Neuroendocrine Tumors presented at this year’s ASCO-GI Cancers Symposium.</p>
VIEW THE TOPICS
- Gastric Neuroendocrine Tumors: Updates, Perspectives, and Controversies
- Gastroenteropancreatic Neuroendocrine Tumors: Clinical Trials
- Potential Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors
- Repeat Peptide Receptor Radionuclide Therapy for Neuroendocrine Neoplasms
- Surveillance After Complete Resection of Gastroenteropancreatic Neuroendocrine Tumors
- Treating Midgut vs Non-Midgut GEP-NETs: Real-World Data
This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology.



